共 50 条
- [31] EFFICACY AND SAFETY OF MIRIKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 LUCENT-2 STUDYGASTROENTEROLOGY, 2022, 162 (07) : S1393 - S1394Dubinsky, Marla C.Irving, Peter M.Li, XingyuanHowaldt, StefaniePokrotnieks, JurisKrueger, Kathryn A.Laskowski, JanelleLissoos, TrevorMilata, JoeMorris, NathanArora, VipinMilch, CatherineSands, Bruce E.
- [32] Efficacy and safety of mirikizumab as maintenance therapy in patients with moderately to severely active ulcerative colitis: Results from the Phase 3 LUCENT-2 studyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 133 - 133Begun, J.Dubinsky, M. C.Irving, P. M.Li, X.Howaldt, S.Pokrotnieks, J.Krueger, K.Laskowski, J.Lissoos, T.Milata, J.Morris, N.Arora, V.Milch, C.Sands, B. E.
- [33] THE SAFETY PROFILE OF UPADACITINIB MAINTENANCE THERAPY IN ULCERATIVE COLITIS IN THE PHASE 3 U-ACHIEVE STUDY IS CONSISTENT WITH THAT IN APPROVED INDICATIONSGASTROENTEROLOGY, 2022, 162 (07) : S967 - S967Colombel, Jean FredericPanaccione, RemoNakase, HiroshiBurmester, Gerd R.Cohen, Stanley B.Mease, PhilipGuttman-Yassky, EmmaLiu, JianzhongZhou, WenIlo, DapoHiggins, Peter D.
- [34] Bowel Urgency and Abdominal Pain in Patients With Moderately to Severely Active Ulcerative Colitis in the Etrasimod ELEVATE UC Clinical Program: A Post Hoc AnalysisAMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S889 - S890Dubinsky, Marla C.Chaparro, MariaArmuzzi, AlessandroIrving, Peter M.Allez, MatthieuPanaccione, RemoGoetsch, MartinaBartolome, LaurenBananis, EustratiosWu, JosephWosik, KarolinaBhattacharjee, AbhishekSmith, Christina C.Sands, Bruce E.
- [35] The safety profile of upadacitinib maintenance therapy in ulcerative colitis in the Phase 3 U-ACHIEVE study is consistent with that in approved indicationsJOURNAL OF CROHNS & COLITIS, 2022, 16 : I514 - I514Colombel, J. F.Panaccione, R.Nakase, H.Burmester, G.Cohen, S. B.Mease, P.Guttman-Yassky, E.Liu, J.Zhou, W.Ilo, D.Higgins, P.
- [36] MIRIKIZUMAB TREATMENT IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITISINFLAMMATORY BOWEL DISEASES, 2020, 26 : S10 - S11Dubinsky, MarlaLee, Scott D.Panaccione, RemoAbreu, MariaVermeire, SeverineLissoos, TrevorMorris, NathanArora, VipinDong, YanNaegeli, AprilSands, Bruce
- [37] The safety profile of upadacitinib maintenance therapy in ulcerative colitis in the Phase 3 U-ACHIEVE study is consistent with that in approved indicationsJOURNAL OF CROHNS & COLITIS, 2022, 16 : I514 - I514Colombel, J. F.Panaccione, R.Nakase, H.Burmester, G.Cohen, S. B.Mease, P.Guttman-Yassky, E.Liu, J.Zhou, W.Ilo, D.Higgins, P.
- [38] MIRIKIZUMAB TREATMENT IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITISGASTROENTEROLOGY, 2020, 158 (03) : S17 - S18Dubinsky, MarlaLee, Scott D.Panaccione, RemoAbreu, MariaVermeire, SeverineLissoos, TrevorMorris, NathanArora, VipinDong, YanNaegeli, AprilSands, Bruce
- [39] PRA023 Improved Bowel Urgency, Nocturnal Bowel Movement, Nocturnal Waking, and Abdominal Pain in a Phase 2 Trial of Patients With Moderately to Severely Active Ulcerative ColitisAMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S888 - S888Dubinsky, Marla C.Rubin, David T.Peyrin-Biroulet, LaurentSands, Bruce E.Danese, SilvioMelmed, GilBoland, Brigid S.Nguyen, Deanna D.Dinh, QuinnLu, J. D.Dong, BinMa, ChristopherRitter, Timothy E.Panaccione, Remo
- [40] EFFECT OF UPADACITINIB ON LIPID PROFILES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: POOLED ANALYSIS OF PHASE 3 INDUCTION AND MAINTENANCE STUDIES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE OR ULCERATIVE COLITISGASTROENTEROLOGY, 2024, 166 (05) : S813 - S813Dubinsky, Marla C.Ha, ChristinaArmuzzi, AlessandroIrving, Peter M.Fumery, MathurinAnyanwu, SamuelLacerda, Ana P.Wang, TaoSuravaram, SmithaKligys, KristinaShah, SaajanDuncan, BenjaminRubin, David T.